The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
US stocks tipped higher on Tuesday, with the S&P 500 clinching a fresh record, as Wall Street shrugged off fresh data that showed surprisingly strong growth in the US economy over the summer that led ...
Women’s health startups face advertising barriers that block medically accurate care from reaching patients. Data shows how ...
The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to ...
The movie gets at least one thing right: Rebooting the shlocky, widely-panned creature-feature, starring Jack Black and Paul ...
Investor's Business Daily on MSN
Stock market today: Indexes mixed after GDP data surprise; Alphabet extends gains (live coverage)
The Dow Jones index fell Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
US stocks wobbled on Tuesday after fresh data showed surprisingly strong growth in the US economy over the summer, leading investors to trim bets on near-term interest-rate cuts. Tuesday brought a ...
Across the U.S., UK, Europe, and Canada, Donald Trump and his allies supercharged climate denial, boost fossil fuels, and ...
While there was an explosion in the use of GLP-1 drugs in 2025, two pharmaceutical giants are preparing to debut their oral ...
The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results